Literature DB >> 6903116

In vitro antimicrobial susceptibility of Actinobacillus actinomycetemcomitans.

J Slots, R T Evans, P M Lobbins, R J Genco.   

Abstract

The agar dilution technique was used for determination of the antibiotic susceptibilities of 57 oral isolates and 2 nonoral isolates of Actinobacillus actinomycetemcomitans. Tetracycline, minocycline, and chloramphenicol inhibited more than 96% of the strains tested at a concentration of less than or equal to 2 micrograms/ml; 89% of the strains were inhibited by 2 micrograms of carbenicillin per ml. The other antimicrobial agents tested were less active. Approximately 10% of the A. actinomycetemcomitans strains were resistant to ampicillin, erythromycin, and penicillin G at concentrations of 32 to 64 micrograms/ml. These data suggest that tetracycline and minocycline may be valuable drugs in the treatment of A. actinomycetemcomitans infections.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6903116      PMCID: PMC283931          DOI: 10.1128/AAC.18.1.9

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Actinobacillus actinomycetam comitans as the sole infecting agent in a human being.

Authors:  T THJØTTA; S SYDNES
Journal:  Acta Pathol Microbiol Scand       Date:  1951

2.  Studies on the aetiology of human actinomycosis. II. Do the other microbes of actinomycosis possess virulence?

Authors:  P HOLM
Journal:  Acta Pathol Microbiol Scand       Date:  1951

3.  Brain abscess due to Actinobacillus actinomycetemcomitans.

Authors:  B F Martin; B M Derby; G N Budzilovich; J Ransohoff
Journal:  Neurology       Date:  1967-09       Impact factor: 9.910

4.  Bacterial endocarditis due to Actinobacillus actinomycetemcomitans.

Authors:  R M Vogelzang
Journal:  Arch Intern Med       Date:  1967-07

5.  Subacute bacterial endocarditis due to Actinobacillus actinomycetemcomitans.

Authors:  P Serra; M Tonato
Journal:  Am J Med       Date:  1969-11       Impact factor: 4.965

6.  Urinary tract infection due to Actinobacillus actinomycetemcomitans.

Authors:  T R Townsend; J Y Gillenwater
Journal:  JAMA       Date:  1969-10-20       Impact factor: 56.272

7.  [Studies on the sensitivity of Actinomyces israeli and 2 of its most frequently associated anaerobic bacteria to new antibiotics (6-D-alpha-aminobenzylpenicillin, aminosidin, colistin, kanamycin, novobiocin, oleandomycin, spiramycin, vancomycin)].

Authors:  D Fritsche
Journal:  Z Hyg Infektionskr       Date:  1964

8.  Infection due to Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus.

Authors:  M I Page; E O King
Journal:  N Engl J Med       Date:  1966-07-28       Impact factor: 91.245

9.  Actinobacillus actinomycetemcomitans endocarditis.

Authors:  B F Overholt
Journal:  Arch Intern Med       Date:  1966-01

10.  A study of the bacteria associated with advancing periodontitis in man.

Authors:  A C Tanner; C Haffer; G T Bratthall; R A Visconti; S S Socransky
Journal:  J Clin Periodontol       Date:  1979-10       Impact factor: 8.728

View more
  17 in total

1.  Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  [Cutaneous infection with Aggregatibacter actinomycetemcomitans].

Authors:  J Böhme; T E Glaenz; A Kaiser; C Allmacher
Journal:  Hautarzt       Date:  2014-09       Impact factor: 0.751

3.  Heterogeneity of Actinobacillus actinomycetemcomitans strains in various human infections and relationships between serotype, genotype, and antimicrobial susceptibility.

Authors:  S Paju; P Carlson; H Jousimies-Somer; S Asikainen
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Failure of vancomycin prophylaxis and treatment for Actinobacillus actinomycetemcomitans endocarditis.

Authors:  R H Eng; S M Smith; E J Goldstein; K T Miyasaki; S E Quah; F Buccini
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

5.  In vitro activity of antibiotics alone and in combination against Actinobacillus actinomycetemcomitans.

Authors:  R Yogev; D Shulman; S T Shulman; W G Glogowski
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

6.  Minimal inhibitory concentrations of various antimicrobial agents for human oral anaerobic bacteria.

Authors:  P J Baker; J Slots; R J Genco; R T Evans
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

7.  Antimicrobial susceptibilities of bacteria associated with periodontal disease.

Authors:  V L Sutter; M J Jones; A T Ghoneim
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

8.  Salient Biochemical Characters of Actinobacillus actinomycetemcomitans.

Authors:  J Slots
Journal:  Arch Microbiol       Date:  1982-02       Impact factor: 2.552

9.  Endarteritis and mycotic aortic aneurysm caused by an oral strain of Actinobacillus actinomycetemcomitans.

Authors:  M C Martín; M T Andrés; J F Fierro; F J Méndez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

10.  Vertebral osteomyelitis due to coccobacilli of the HB group.

Authors:  M Farrington; S J Eykyn; M Walker; R E Warren
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.